AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2020
Jun 17, 2020
33153_dirs_2020-06-17_2d0e8126-93ce-47e2-b350-db1245531091.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO (MLAB)
CIK: 0000724004
Period of Report: 2020-06-15
Reporting Person: Sakys John (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-15 | Restricted Stock Units - 1 | $ | A | 1189 | Acquired | Common Stock (1189) | Direct | |
| 2020-06-15 | Non Qualified Stock Option | $226.72 | A | 3951 | Acquired | 2026-06-15 | Common Stock (3951) | Direct |
| 2020-06-15 | Restricted Stock Units - 2 | $ | A | 681 | Acquired | Common Stock (681) | Direct |
Footnotes
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates
F3: Not Applicable
F4: NSOs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates
F5: RSUs that cliff vest June 15, 2021
F6: RSUs granted for 10% salary reduction for 12 months and conversion of 60% of cash bonus target for Fiscal Year 21
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6